22.05.2022 Views

DƯỢC LÍ Goodman & Gilman's The Pharmacological Basis of Therapeutics 12th, 2010

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

770 refractory to drugs that block the sympathetic nervous

system or to vasodilator drugs, because these drugs

engender a state in which the blood pressure is very volume

dependent. Therefore, it is appropriate to consider

the use of thiazide-class diuretics in doses of 50 mg of

daily hydrochlorothiazide equivalent when treatment

with appropriate combinations and doses of three or

more drugs fails to yield adequate control of the blood

pressure. Alternatively, there may be a need to use

higher-capacity diuretics such as furosemide, especially

if renal function is not normal, in some of these patients.

Dietary Na + restriction is a valuable adjunct to the management

of such refractory patients and will minimize

the dose of diuretic that is required. This can be achieved

by a modest restriction of Na + intake to 2 g daily. More

stringent Na + restriction is not feasible for most patients.

Because the degree of K + loss relates to the amount of

Na + delivered to the distal tubule, such restriction of Na +

can minimize the development of hypokalemia and

alkalosis. The effectiveness of thiazides as diuretics or

antihypertensive agents is progressively diminished when

the glomerular filtration rate falls below 30 mL/min. One

exception is metolazone, which retains efficacy in patients

with this degree of renal insufficiency.

Most patients will respond to thiazide diuretics with

a reduction in blood pressure within about 4-6 weeks.

Therefore, doses should not be increased more often than

every 4-6 weeks. There is no way to predict the antihypertensive

response from the duration or severity of the

hypertension in a given patient, although diuretics are

unlikely to be effective as sole therapy in patients with

stage 2 hypertension (Table 27–4). Because the effect of

thiazide diuretics is additive with that of other antihypertensive

drugs, combination regimens that include these

diuretics are common and rational. A wide range of fixeddose

combination products containing a thiazide are marketed

for this purpose. Diuretics also have the advantage

of minimizing the retention of salt and water that is commonly

caused by vasodilators and some sympatholytic

drugs. Omitting or underutilizing a diuretic is a frequent

cause of “resistant hypertension.”

SECTION III

MODULATION OF CARDIOVASCULAR FUNCTION

Adverse Effects and Precautions. The adverse effects of

diuretics are discussed in Chapter 25. Some of these

determine whether patients can tolerate and adhere to

diuretic treatment.

Erectile dysfunction is a troublesome adverse effect of the

thiazide-class diuretics, and physicians should inquire specifically

regarding its occurrence in conjunction with treatment with these

drugs. Gout may be a consequence of the hyperuricemia induced by

these diuretics. The occurrence of either of these adverse effects is

a reason for considering alternative approaches to therapy. However,

precipitation of acute gout is relatively uncommon with low doses of

diuretics. Hydrochlorothiazide may cause rapidly developing, severe

hyponatremia in some patients. Thiazides inhibit renal Ca 2+ excretion,

occasionally leading to hypercalcemia; although generally

mild, this can be more severe in patients subject to hypercalcemia,

such as those with primary hyperparathyroidism. The thiazideinduced

decreased Ca 2+ excretion may be used therapeutically in

patients with osteoporosis or hypercalciuria.

Some other effects of thiazide diuretics are laboratory observations

that are of concern primarily because they are putative surrogate

markers for adverse drug effects on morbidity and mortality.

The effects of diuretic drugs on several surrogate markers for adverse

outcomes merit consideration. The K + depletion produced by thiazide-class

diuretics is dose dependent and is variable among individuals,

such that a subset of patients may become substantially K +

depleted on diuretic drugs. Given chronically, even small doses lead

to some K + depletion.

There are two types of ventricular arrhythmias that are thought

to be enhanced by K + depletion. One of these is polymorphic ventricular

tachycardia (torsades de pointes), which is induced by a number

of drugs, including quinidine. Drug-induced polymorphic ventricular

tachycardia is initiated by abnormal ventricular repolarization; because

K + currents normally mediate repolarization, drugs that produce K +

depletion potentiate polymorphic ventricular tachycardia. Accordingly,

thiazide diuretics should not be given together with drugs that can

cause polymorphic ventricular tachycardia (see Chapter 29).

The most important concern regarding K + depletion is its

influence on ischemic ventricular fibrillation, the leading cause of

sudden cardiac death and a major contributor to cardiovascular mortality

in treated hypertensive patients. Studies in experimental animals

have demonstrated that K + depletion lowers the threshold for

electrically induced ventricular fibrillation in the ischemic

myocardium and also increases spontaneous ischemic ventricular

fibrillation (Curtis and Hearse, 1989). There is a positive correlation

between diuretic dose and sudden cardiac death, and an inverse correlation

between the use of adjunctive K + -sparing agents and sudden

cardiac death (Siscovick et al., 1994). One controlled clinical

trial demonstrated a significantly greater occurrence of sudden cardiac

death in patients treated with 50 mg of hydrochlorothiazide

daily in comparison with the β receptor antagonist metoprolol

(Medical Research Council Working Party, 1992).

Thiazide diuretics have been associated with changes in

plasma lipids and glucose tolerance that have led to some concern.

The clinical significance of the changes has been disputed.

Nonetheless, clinical studies demonstrate the efficacy of the thiazide

diuretics in reducing cardiovascular risk (ALLHAT Officers, 2002).

All of the thiazide-like drugs cross the placenta, but they have

not been shown to have direct adverse effects on the fetus. However,

if administration of a thiazide is begun during pregnancy, there is a

risk of transient volume depletion that may result in placental hypoperfusion.

Because the thiazides appear in breast milk, they should

be avoided by nursing mothers.

Other Diuretic Antihypertensive Agents

The thiazide diuretics are more effective antihypertensive

agents than are the loop diuretics, such as

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!